Media Opportunity: M Lab(TM) Collaboration Center Opens in Greater Boston
WHO: Reporters, photographers and videographers are
invited to tour the new M Lab(TM) Collaboration
Center at MilliporeSigma, a global life science
company, which will also cut the ribbon on its
new, 280,000-square-foot Life Science Center -
Burlington.
WHAT: MilliporeSigma's M Lab(TM) Collaboration Center -
a laboratory that simulates a real manufacturing
environment and gives customers the freedom and
flexibility to experiment without risk to their
manufacturing facilities - is celebrating its
grand opening. The center is a shared exploratory
environment where the company's scientists and
engineers work side-by-side with customers on
the latest biomanufacturing techniques. The goal
is to help bring life-enhancing therapies to
market quickly and efficiently.
Attending media can:
Tour the 14,000-square-foot M Lab(TM)
Collaboration Center.
Record video and take
photographs.
Learn more about the problem
solving that goes on inside the center.
Learn
more about MilliporeSigma and its aim to solve
the toughest problems in life science by
collaborating with the global scientific
community.
WHEN: Wednesday, October 11, 11:15 a.m. EDT
(M Lab(TM) Collaboration Center tour)
WHERE: MilliporeSigma
400 Summit Drive
Burlington, Massachusetts 01803
Ribbon-cutting event starts at 10 a.m. EDT
If you are unable to attend the tour, please
contact Karen Tiano at (978) 495-0093 for further
information for a story or to arrange an
interview.
WHY: MilliporeSigma is expanding opportunities for life
science companies and biotechs to partner,
collaborate and solve the toughest problems in
Life Science.
The company has developed a dynamic setting that
promotes customer collaboration from pre-
clinical through full-scale production.
Customers can explore the latest technologies,
apply best practices and perform new tests, all
while collaborating to find solutions to process
development challenges, big and small.
About the Life Science Business of Merck KGaA, Darmstadt, Germany
The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has 20,000 employees and 60 manufacturing sites worldwide, with a portfolio of more than 300,000 products enabling scientific discovery. Udit Batra is the global chief executive officer of MilliporeSigma.
Merck KGaA, Darmstadt, Germany completed its $17 billion acquisition of Sigma-Aldrich in November 2015, creating a leader in the $125 billion global life science industry.
Merck KGaA, Darmstadt, Germany is a leading company for innovative and top-quality high-tech products in health care, life science and performance materials. The company has five businesses-- Biopharmaceuticals, Consumer Health, Allergopharma, Life Science and Performance Materials--and generated sales of EUR15 billion in 2016. More than 50,000 employees work in 66 countries to improve the quality of life for patients, to foster the success of customers and to help meet global challenges.
Merck KGaA, Darmstadt, Germany is the world's oldest pharmaceutical and chemical company--since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent interest, the founding family remains the majority owner of the company to this day. The company holds the global rights to the name and the trademark "Merck" internationally except for the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
Your Contact
Karen Tiano +1 978 495 0093
/PRNewswire -- Oct. 6/
SOURCE MilliporeSigma
